Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Cavos Biotech is developing a multi-level genomic algorithm to uncover the genetic base of extraordinary cancer resistance found across various and specific animals.
Harnessing the latest in data and genomics, the company uses high-resolution identification methods to uncover existing anti-cancer mechanisms and novel drug targets in order to revolutionize the way drug targets are discovered and identified.